Shenji Bio

About:

Shenji Bio focuses on the research and development of raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies.

Website: http://www.syngenebio.com

Top Investors: LYFE Capital, Lake Bleu Capital, Sherpa Healthcare Partners, Lenovo Star

Description:

Shenji Bio focuses on the research and development of fundamental raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies. As a development direction, Shenji Bio provides cost-effective products and addresses clinical unmet needs. It has gradually entered the upstream core raw material fields of IVD, mRNA, CGT, and other industries, and has established a high-quality key common technology platform to provide overall solutions for the life science field's development.

Total Funding Amount:

300M CNY

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2018-07-01

Contact Email:

hr(AT)syngenebio.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2022-04-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai